AIM
OXFD

Aigen Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Aigen Investment Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,327
Closed -$268K – 990
2020
Q4 		$268K Sell
15,327
-410
-3% -$5.75K 0.04% 585
2020
Q3 		$184K Sell
15,737
-17,813
-53% -$236K 0.02% 668
2020
Q2 		$436K Buy
+33,550
New +$403K 0.06% 507

Aigen Investment Management's OXFD Position: Q1 2021 in Review

Aigen Investment Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 15,327 shares — an estimated $268K sold.

Aigen Investment Management first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $436K in Q2 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Aigen Investment Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Aigen Investment Management sold 15,327 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $268K.
  • Aigen Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
  • Aigen Investment Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $436K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Aigen Investment Management's 13F filing for Q1 2021, filed 11 May 2021.